Issue 3/2005
Content (9 Articles)
The relationship between productivity and health-related QOL
Werner B. F. Brouwer, Willem-Jan Meerding, Leida M. Lamers, Johan L. Severens
Penny and pound wise
Mike F. van Oostenbruggen, Ronald B. Jansen, Katja Mur, Huib Kooijman
The economic impact of neuropsychiatric symptoms in Alzheimer’s disease
Daniel L. Murman, Christopher C. Colenda
International variation in resource utilisation and treatment costs for rheumatoid arthritis
Hubertus Rosery, Rito Bergemann, Stefanie Maxion-Bergemann
A pharmacoeconomic evaluation of statins in the treatment of hypercholesterolaemia in the primary care setting in Spain
Pedro J. Tárraga-López, Ángel Celada-Rodríguez, Miguel Cerdán-Oliver, Juan Solera-Albero, José M. Ocaña-López, Mateo A. López-Cara, Jaime De Miguel-Clave
The case of tumour necrosis factor-α inhibitors in the treatment of rheumatoid arthritis
Jan Sørensen, Lis S. Andersen
Cost-effectiveness model of long-acting risperidone in schizophrenia in the US
Natalie C. Edwards, Marcia F. T. Rupnow, Chris L. Pashos, Marc F. Botteman, Ronald J. Diamond